RT Journal Article
SR Electronic
T1 Serum lipid profile changes and their clinical diagnostic significance in COVID-19 Mexican Patients
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.08.24.20169789
DO 10.1101/2020.08.24.20169789
A1 Osuna-Ramos, Juan Fidel
A1 Rendón-Aguilar, Horacio
A1 Jesús-González, Luis Adrián De
A1 Reyes-Ruiz, José Manuel
A1 Espinoza-Ortega, Arely Montserrat
A1 Ochoa-Ramírez, Luis Antonio
A1 Romero-Utrilla, Alejandra
A1 Ríos-Burgueño, Efrén
A1 Soto-Almaral, Alejandro
A1 Ríos-Tostado, Juan José
A1 Romero-Quintana, José Geovanni
A1 Ponce-Ramos, Héctor
A1 Farfan-Morales, Carlos Noe
A1 Ángel, Rosa María del
A1 Barajas-Martínez, Héctor
A1 Rodríguez-Millán, José
A1 Velarde-Félix, Jesús Salvador
YR 2020
UL http://medrxiv.org/content/early/2020/08/26/2020.08.24.20169789.abstract
AB Background COVID-19 has been recognized as an emerging and rapidly evolving health condition. For this reason, efforts to determine changes in laboratory parameters of COVID-19 patients as biomarkers are urgent. Lipids are essential components of the human body, and their modulation has been observed implicated in some viral infections.Methods To evaluate the clinical diagnosis utility of the lipid profile changes in Mexican COVID-19 patients, the lipid profile of one hundred two COVID-19 positive patients from three hospitals in Culiacan, Sinaloa in northwest Mexico, was analyzed. ROC curves and binary logistic regression analysis were used as a predictive model to determine their clinical diagnostic utility.Results Significant changes in the serum lipid profile of patients with COVID-19, such as low levels of cholesterol, LDL, and HDL, while high triglycerides and VLDL were observed. The same abnormalities in the lipid profile among non-critical and critical COVID-19 patients were detected. The predictive model analysis suggests that cholesterol and LDL have AUC values of 0.710 and 0.769, respectively, for COVID-19 (p= 0.0002 and p= <0.0001), and LDL low levels might be a risk factor for critical COVID-19 (OR= 2.07, 95% IC: 1.18 to 3.63; p= 0.01).Conclusion Our findings suggest that low cholesterol and LDL levels could be considered an acceptable predictor for COVID-19, and low levels of LDL might be a risk factor for critical COVID-19 patients.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNoneAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:The Research Ethical Committee of Hospital General de Culiacan "Bernardo J Gastelum" approved the study, and some patients writing informed consent, and in another, the consent was verbal.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesNo suplementary material is included